H. Schühlen

发表

Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2001, Circulation.

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, Journal of the American College of Cardiology.

Predictive factors of restenosis after coronary stent placement.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1997, Journal of the American College of Cardiology.

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

W. Rottbauer, M. Fischer, H. Schunkert, 2019, The New England journal of medicine.

[Deterministic record linkage with indirect identifiers: data of the Berlin Myocardial Infarction Registry and the AOK Nordost for patients with myocardial infarction].

R. Busse, H. Theres, H. Schühlen, 2015, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

Restenosis after coronary placement of various stent types.

K Ulm, A. Kastrati, J. Mehilli, 2001, The American journal of cardiology.

Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement.

Jörg Hausleiter, Adnan Kastrati, Albert Schömig, 2004, American heart journal.

Digital angiographic impulse response analysis of regional myocardial perfusion. Detection of autoregulatory changes in nonstenotic coronary arteries induced by collateral flow to adjacent stenotic arteries.

H. Schühlen, J. Whiting, N L Eigler, 1994, Circulation.

Intracoronary stenting and risk for major adverse cardiac events during the first month.

M. Hadamitzky, J. Hausleiter, A. Kastrati, 1998, Circulation.

A randomized trial comparing phosphorylcholine‐coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries

J. Hausleiter, A. Kastrati, J. Mehilli, 2004, Journal of internal medicine.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, The New England journal of medicine.

Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2006, JAMA.

Mechanical Reperfusion in Patients With Acute Myocardial Infarction Presenting More Than 12 Hours From Symptom Onset: A Randomized Controlled Trial

S. Nekolla, M. Schwaiger, A. Kastrati, 2005 .

Therapy-Dependent Influence of Time-to-Treatment Interval on Myocardial Salvage in Patients With Acute Myocardial Infarction Treated With Coronary Artery Stenting or Thrombolysis

S. Nekolla, M. Schwaiger, A. Kastrati, 2003, Circulation.

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry.

J. Brachmann, H. Thiele, H. Schühlen, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

A. Kastrati, J. Mehilli, H. Schühlen, 2004 .

Randomized Comparison of Ticagrelor versus Prasugrel in Patients with Acute Coronary Syndrome and Planned Invasive Strategy—Design and Rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial

H. Schunkert, A. Kastrati, F. Neumann, 2014, Journal of Cardiovascular Translational Research.

Pre-specified vs. post-hoc subgroup analyses: are we wiser before or after a trial has been performed?

H. Schühlen, 2014, European heart journal.

Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.

M. Hadamitzky, H. Schühlen, A. Schömig, 1997, Circulation.

Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Prognostic value of the modified american college of Cardiology/American heart association stenosis morphology classification for long-term angiographic and clinical outcome after coronary stent placement.

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.

The Emergency Medical Care of Patients With Acute Myocardial Infarction.

H. Theres, H. Schühlen, W. Rutsch, 2016, Deutsches Arzteblatt international.

Routine early invasive strategy and in-hospital mortality in women with non-ST-elevation myocardial infarction: results from the Berlin Myocardial Infarction Registry (BMIR).

H. Theres, H. Schühlen, B. Maier, 2012, International journal of cardiology.

Randomized Clinical Trial of Abciximab in Diabetic Patients Undergoing Elective Percutaneous Coronary Interventions After Treatment With a High Loading Dose of Clopidogrel

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Circulation.

Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.

M. Hadamitzky, J. Hausleiter, A. Kastrati, 1997, Circulation.

A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, American heart journal.

Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.

S. Nekolla, M. Schwaiger, A. Kastrati, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, The American journal of cardiology.

Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.

M. Schwaiger, A. Kastrati, J. Mehilli, 2003, European heart journal.

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen.

A. Kastrati, J. Dirschinger, J. Pache, 2001, Journal of the American College of Cardiology.

Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen.

A. Kastrati, J. Dirschinger, J. Pache, 2001, The American journal of cardiology.

Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The American journal of cardiology.

Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high load

A. Kastrati, J. Mehilli, J. Dirschinger, 1997, American heart journal.

Antiplatelet vs. anticoagulation treatment after intracoronary Palmaz-Schatz stent placement in acute myocardial infarction — A prospective randomized trial

M. Hadamitzky, F. Neumann, H. Schühlen, 1996 .

Kongressbericht: Highlights vom 11. Great Minds Œ European PCI Expert Meeting, 23.Œ24. Juni 2017 in Budapest

H. Schühlen, K. Huber, M. Rohla, 2019 .

Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, American heart journal.

Angiographic and clinical follow-up of patients with asymptomatic restenosis after coronary stent

A. Kastrati, H. Schühlen, S. Elezi, 1998 .

Distal protection device reduces adverse cardiac events compared with conventional angioplasty guidewire when stenting stenotic venous grafts

H. Schühlen, 2002 .

Clinical and angiographic outcome after stent placement for chronic coronary occlusion.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1998, The American journal of cardiology.

Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re liquid-filled balloon.

M. Schwaiger, A. Kastrati, J. Dirschinger, 2001, The American journal of cardiology.

Grading the angiographic extent of collateral filling

H. Schühlen, J. Whiting, N. Eigler, 1994, The International Journal of Cardiac Imaging.

Risk factor analysis for stent occlusion within the first month after successful coronary stent placement

J. Hausleiter, A. Kastrati, J. Dirschinger, 1998 .

906-64 Doppler Tissue Imaging of Left Ventricular Myocardium — Initial Results During Pharmacologic Stress

H. Schühlen, A. Schömig, C. Firschke, 1995 .

Acute Myocardial Infarction Admissions in Berlin During the COVID-19 Pandemic.

H. Schühlen, H. Dreger, B. Maier, 2020, Deutsches Arzteblatt international.

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, JAMA.

951-72 Intravascular Ultrasound Guided Optimized Emergency Coronary Palmaz Schatz Stent Placement without Post Procedural Systemic Anticoagulation

F. Neumann, H. Schühlen, C. Schmitt, 1995 .

Four‐Year Experience With Palmaz‐Schatz Stenting in Coronary Angioplasty Complicated by Dissection With Threatened or Present Vessel Closure

A. Kastrati, F. Neumann, H. Schühlen, 1994, Circulation.

A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, Journal of the American College of Cardiology.

Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.

S. Nekolla, M. Schwaiger, A. Kastrati, 2005, JAMA.

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

M. Hadamitzky, A. Kastrati, F. Neumann, 1996, The New England journal of medicine.

CLINICAL RESEARCH Interventional Cardiology A Randomized Trial Comparing Myocardial Salvage Achieved by Coronary Stenting Versus Balloon Angioplasty in Patients With Acute Myocardial Infarction Considered Ineligible for Reperfusion Therapy

Adnan Kastrati, Markus Schwaiger, Albert Schömig, 2004 .

Gender and restenosis after coronary artery stenting.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, European heart journal.

Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.

M. Hadamitzky, A. Kastrati, J. Dirschinger, 1997, Journal of the American College of Cardiology.

Digital Angiographic Assessment of the Physiological Changes to the Regional Microcirculation Induced by Successful Coronary Angioplasty

H. Schühlen, A. Zeiher, J. Whiting, 1994, Circulation.

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, European heart journal.

Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation.

P. Boekstegers, G. Steinbeck, A. Kastrati, 1999, Circulation.

Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.

M. Hadamitzky, A. Kastrati, J. Mehilli, 2003, The American journal of medicine.

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

A. Kastrati, J. Mehilli, J. Dirschinger, 2005, The New England journal of medicine.

Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR‐DIRECT trial)

A. Kastrati, J. Mehilli, J. Dirschinger, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A randomized trial comparing the hand‐mounted JoStent with the premounted Multi‐Link Duet stent in patients with coronary artery disease

A. Kastrati, J. Mehilli, J. Dirschinger, 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.

A. Kastrati, J. Mehilli, J. Dirschinger, 2000, Circulation.

Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.

A. Kastrati, J. Mehilli, J. Dirschinger, 2003, American heart journal.

Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of medicine.

Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement.

A. Kastrati, J. Dirschinger, H. Schühlen, 1997, Circulation.

Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients

P. Boekstegers, G. Steinbeck, A. Kastrati, 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

720-6 Stenting for Progressive Dissection During PTCA: Clinical, Angiographic and Intravascular Ultrasound Criteria to Define a Low-risk Group not Requiring Subsequent Anticoagulation

A. Kastrati, H. Schühlen, A. Schömig, 1995 .

One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.

A. Kastrati, J. Mehilli, F. Neumann, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Implementation of the ESC STEMI guidelines in female and elderly patients over a 20-year period in a large German registry

H. Theres, H. Schühlen, H. Dreger, 2023, Clinical Research in Cardiology.

Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: results from the COViK study

H. Schühlen, C. Peine, T. Harder, 2023, medRxiv.

Interlesion dependence of the risk for restenosis in patients with coronary stent placement in in multiple lesions.

A. Kastrati, J. Dirschinger, H. Schühlen, 1998, Circulation.

Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, Journal of the American College of Cardiology.

Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022

H. Schühlen, S. Gläser, E. Hildt, 2022, Vaccine.

Stenting for small coronary vessels: a contestable winner.

A. Kastrati, H. Schühlen, A. Schömig, 2001, Journal of the American College of Cardiology.

Digital angiographic impulse response analysis of regional myocardial perfusion. Estimation of coronary flow, flow reserve, and distribution volume by compartmental transit time measurement in a canine model.

A Zeiher, H. Schuhlen, H. Schühlen, 1991, Circulation research.

Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).

A. Kastrati, J. Mehilli, J. Dirschinger, 2002, The American journal of cardiology.

The European cobalt STent with Antiproliferative for Restenosis trial (EuroSTAR): 12 month results.

P. Serruys, P. Stella, H. Schühlen, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparing routine administrative data with registry data for assessing quality of hospital care in patients with myocardial infarction using deterministic record linkage

R. Busse, H. Theres, H. Schühlen, 2016, BMC Health Services Research.

Changes in treatment for NSTEMI in women and the elderly over the past 16 years in a large real-world population.

H. Theres, H. Schühlen, U. Landmesser, 2020, International journal of cardiology.

Stenting for Small Coronary Vessels : A

A. Kastrati, H. Schühlen, A. Schömig, 2016 .

A. Kastrati, J. Mehilli, J. Dirschinger, 1999, Circulation.